Eurofins Scientific SE (ERF) - Financial and Strategic SWOT Analysis Review

Date: March 29, 2016
Pages: 55
Price:
US$ 300.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: E5D61858624EN
Leaflet:

Download PDF Leaflet

Eurofins Scientific SE (ERF) - Financial and Strategic SWOT Analysis Review
Eurofins Scientific SE (ERF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Eurofins Scientific SE (Eurofins) is a life sciences company, which provides a range of analytical testing services to clients in various industries. The company offers food and feed testing, biopharma services, pharma discovery services, genomic pharma services, pharma early development, pharma central laboratory, biopharma product testing, genomic services, agro-science services, product testing, forensic services, environmental testing and Registration, Evaluation, Authorization and Restriction of Chemicals (REACH) services. Its analytical methods help in evaluating the safety, identity, composition, origin, authenticity and purity of biological products and substances. It harnesses its expertise in logistics and information technology to deliver a range of services. The company operates across Europe, North and South America, and Asia-Pacific. Eurofins is headquartered in Luxembourg.

Eurofins Scientific SE Key Recent Developments

Mar 01, 2016: Eurofins Genomics Opens State-of-the-Art Facility in Louisville, KY
Feb 29, 2016: Outstanding 2015 results above recently upgraded objectives on all metrics Full year revenues up 38%, EBITDA up 50% Organic growth over 9.5% in Q4, almost 7.5% for the full year
Feb 22, 2016: Eurofins Microbiology Opens State-of-the-Art Laboratory in Louisville, KY
Nov 24, 2015: Eurofins’ 2016 Budget process highlights Q4 2015 growth close to 50% and strong outlook for 2016
Oct 26, 2015: Eurofins raises FY 2015 reported revenue objective to EUR 1.9bn as 36.5% revenue growth in Q3 2015 confirms strong underlying trends

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company. - The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably. - Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance. - Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research. - Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

Eurofins Scientific SE - Key Facts
Eurofins Scientific SE - Key Employees
Eurofins Scientific SE - Key Employee Biographies
Eurofins Scientific SE - Major Products and Services
Eurofins Scientific SE - History
Eurofins Scientific SE - Company Statement
Eurofins Scientific SE - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Eurofins Scientific SE - Business Description
Eurofins Scientific SE - Corporate Strategy
Eurofins Scientific SE - SWOT Analysis
SWOT Analysis - Overview
Eurofins Scientific SE - Strengths
Strength - Dominant Position
Strength - Strong Organic and Inorganic Growth
Strength - Research and Development Capabilities
Eurofins Scientific SE - Weaknesses
Weakness - Contract Breaches
Weakness - Restructuring Impacts Costs
Eurofins Scientific SE - Opportunities
Opportunity - Business Initiatives
Opportunity - Growth Drivers
Opportunity - Inorganic Growth Strategies
Opportunity - Growing Healthcare and Pharmaceuticals Market
Eurofins Scientific SE - Threats
Threat - Intense Competition
Threat - Intellectual Property Risk
Threat - Integration Risks
Eurofins Scientific SE - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Eurofins Scientific SE, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Eurofins Scientific SE, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Eurofins Scientific SE, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Feb 29, 2016: Outstanding 2015 results above recently upgraded objectives on all metrics Full year revenues up 38%, EBITDA up 50% Organic growth over 9.5% in Q4, almost 7.5% for the full year
Nov 24, 2015: Eurofins’ 2016 Budget process highlights Q4 2015 growth close to 50% and strong outlook for 2016
Oct 26, 2015: Eurofins raises FY 2015 reported revenue objective to EUR 1.9bn as 36.5% revenue growth in Q3 2015 confirms strong underlying trends
Aug 31, 2015: Eurofins delivers strong H1 2015 results and brings forward one year to 2016 its objective to exceed EUR 2bn of revenues
Jun 17, 2015: Eurofins signs agreement to develop Bio-Access/Labazur clinical laboratories together with its founder and the medical biologists leading its laboratories
May 11, 2015: Eurofins achieves almost 30% revenue growth in Q1 2015

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Eurofins Scientific SE, Key Facts
Eurofins Scientific SE, Key Employees
Eurofins Scientific SE, Key Employee Biographies
Eurofins Scientific SE, Major Products and Services
Eurofins Scientific SE, History
Eurofins Scientific SE, Subsidiaries
Eurofins Scientific SE, Key Competitors
Eurofins Scientific SE, Annual Ratios
Eurofins Scientific SE, Interim Ratios
Eurofins Scientific SE, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Eurofins Scientific SE, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Eurofins Scientific SE, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Eurofins Scientific SE, Performance Chart (2011 - 2015)
Eurofins Scientific SE, Ratio Charts
Eurofins Scientific SE, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Eurofins Scientific SE, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016
Skip to top


Ask Your Question

Eurofins Scientific SE (ERF) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: